These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 429052)

  • 1. Effect of three injections of norethisterone oenanthate on ovarian function.
    Dhall K; Dash RJ; Chadha U; Rastogi GK; Devi PK
    Indian J Med Res; 1979 Jan; 69():93-8. PubMed ID: 429052
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasma levels of norethisterone in women receiving norethisterone oenanthate intramuscularly.
    Howard G; Warren RJ; Fotherby K
    Contraception; 1975 Jul; 12(1):45-52. PubMed ID: 1139949
    [No Abstract]   [Full Text] [Related]  

  • 3. The influence of norethisterone oenanthate on ovarian function.
    Weiner E; Johansson ED
    Acta Endocrinol (Copenh); 1976 Oct; 83(2):386-92. PubMed ID: 989667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacodynamics of a contraceptive vaginal ring releasing norethindrone and estradiol: ovarian function, bleeding control and lipoprotein patterns.
    Victor A; Lithell H; Selinus I; Vessby B
    Ups J Med Sci; 1984; 89(2):179-88. PubMed ID: 6380076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occurrence of ovulation in women receiving the injectable contraceptive norethisterone oenanthate.
    Fotherby K; Howard G; Shrimanker K; Elder M; Bye PG
    Contraception; 1978 Nov; 18(5):535-42. PubMed ID: 729379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma levels of norethindrone after i.m. injection of 200 mg norethindrone enanthate.
    Weiner E; Johansson ED
    Contraception; 1975 Apr; 11(4):419-25. PubMed ID: 1122756
    [No Abstract]   [Full Text] [Related]  

  • 7. Hormonal effects of the 300 microgram norethisterone (NET) minipill. I. Daily steroid levels in 43 subjects during a pretreatment cycle and during the second month of NET administration.
    Landgren BM; Diczfalusy E
    Contraception; 1980 Jan; 21(1):87-113. PubMed ID: 7357872
    [No Abstract]   [Full Text] [Related]  

  • 8. Plasma levels of norethindrone and effect upon ovarian function during treatment with silastic implants containing norethindrone.
    Odlind V; Weiner E; Johansson ED
    Contraception; 1979 Feb; 19(2):197-206. PubMed ID: 428235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Contraception using daily micro-dosage of norethisterone].
    Feldmann HU; Rupek R; Tenhaeff D
    Fortschr Med; 1973 Apr; 91(11):495-9. PubMed ID: 4702395
    [No Abstract]   [Full Text] [Related]  

  • 10. A comparison of the long-acting contraceptive agents norethisterone oenanthate and medroxyprogesterone acetate.
    Chinnatamby S
    Aust N Z J Obstet Gynaecol; 1971 Nov; 11(4):233-6. PubMed ID: 5289724
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacokinetics of norethindrone oenanthate in 5 women after a single dose of norethindrone oenanthate and estradiol valerate.
    Sang GW; Liu XH
    Zhongguo Yao Li Xue Bao; 1986 May; 7(3):255-9. PubMed ID: 2954375
    [No Abstract]   [Full Text] [Related]  

  • 12. Conception control by cyclic injections of norethisterone enanthate and estradiol unducelate.
    Karim M; el-Mahgoub S
    Am J Obstet Gynecol; 1971 Jul; 110(5):740-2. PubMed ID: 5563241
    [No Abstract]   [Full Text] [Related]  

  • 13. [Influence of norethisterone enanthate (SH 393) on ovarian function].
    Jürgensen O; Taubert HD; Naujoks H; Fritz I; Kronauer J
    Acta Endocrinol Suppl (Copenh); 1971; 152():65. PubMed ID: 5313575
    [No Abstract]   [Full Text] [Related]  

  • 14. [Sequential administration of norethisterone and natural oral progesterone during premenopausal menstrual cycle disorders].
    Saarikoski S; Yliskoski M; Penttilä I
    Rev Fr Gynecol Obstet; 1991 Jun; 86(6):475-80. PubMed ID: 1909810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic and pharmacodynamic effects of small doses of norethisterone released from vaginal rings continuously during 90 days.
    Landgren BM; Johannisson E; Masironi B; Diczfalusy E
    Contraception; 1979 Mar; 19(3):253-71. PubMed ID: 572278
    [No Abstract]   [Full Text] [Related]  

  • 16. Release of norethisterone from a bioabsorbable implant in female bonnet monkeys (Macaca radiata).
    Maitra A; Joshi UM; Kholkute SD; Munshi SR; Gupta GN; Tejuja S
    Contraception; 1980 Feb; 21(2):165-73. PubMed ID: 6768491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrence of ovulation after daily, oral administration of 10 mg of norethindrone on day 15-22 and on day 8-15 of the human menstrual cycle.
    Nygren KG; Johansson ED
    Contraception; 1974 Mar; 9(3):257-64. PubMed ID: 4442275
    [No Abstract]   [Full Text] [Related]  

  • 18. The use of norethisterone to suppress menstruation in the intellectually severely retarded woman.
    Roxburgh DR; West MJ
    Med J Aust; 1973 Aug; 2(7):310-3. PubMed ID: 4746398
    [No Abstract]   [Full Text] [Related]  

  • 19. [Modifications in the menstrual pattern during use of hormonal contraceptives].
    de Sampaio LF; Novo NF; de Paiva ER
    Matern Infanc (Sao Paulo); 1974; 33(3):367-70. PubMed ID: 4466962
    [No Abstract]   [Full Text] [Related]  

  • 20. [Restoration of pituitary-ovarian function after long-term application of combined norethindrone oenanthate].
    Shen KY
    Zhonghua Fu Chan Ke Za Zhi; 1988 Sep; 23(5):293-5, 318. PubMed ID: 3150744
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.